Lonza's SSP for Early Phase Delivery
Lonza, the leading custom manufacturer of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries, has recently expanded into a new state-ofthe-art seven-storey small-scale plant (SSP) whose task is to satisfy both clin...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Swiss Chemical Society
2005-01-01
|
| Series: | CHIMIA |
| Subjects: | |
| Online Access: | https://chimia.ch/chimia/article/view/3935 |
| Summary: | Lonza, the leading custom manufacturer of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries, has recently expanded into a new state-ofthe-art seven-storey small-scale plant (SSP) whose task is to satisfy both
clinical supply and process development with sophisticated and lean cGMP-compliant equipment. With this investment, Lonza has now closed the gap between kilo lab and launch plant in order to provide one-stop shopping for API and drug product developmentthrough-approval.
|
|---|---|
| ISSN: | 0009-4293 2673-2424 |